Insider Selling: Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Director Sells 17,500 Shares of Stock

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Get Free Report) Director Molly Harper sold 17,500 shares of the business's stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $22.00, for a total transaction of $385,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.